Quality of life ‐ not reported · children with cancer treated with platinum‐based therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ototoxicity according to NCI CTC v2 criteria with intravenous platinum (combined asymptomatic and symptomatic disease) Objective and subjective audiometric evaluations were performed, no further information provided · children with cancer treated with platinum‐based therapy
Amifostine showed no clear difference in ototoxicity according to NCICTCv2 criteria with intravenous platinum… compared with no otoprotective intervention (low certainty).
1 finding from 1 review
Ototoxicity according to modified Brock criteria with intravenous platinum (combined asymptomatic and symptomatic disease) Audiograms were performed, but no further information provided · children with cancer treated with platinum‐based therapy
Amifostine showed no clear difference in ototoxicity according to modified Brock criteria with intravenous… compared with no otoprotective intervention (low certainty).
1 finding from 1 review
Survival · children with cancer treated with platinum‐based therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Survival (overall and event‐free) ‐ not reported · children with cancer treated with platinum‐based therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tumour response · children with cancer treated with platinum‐based therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tumour response with intra‐arterial platinum (good and partial remission) · children with cancer treated with platinum‐based therapy
Amifostine showed no clear difference in tumour response with intra‐arterial platinum (good and partial… compared with no otoprotective intervention (low certainty).
1 finding from 1 review
Renal toxicity / vomiting/ cardiotoxicity (all grade 3 or higher according to NCI CTCv2 criteria) with intra‐arterial platinum · children with cancer treated with platinum‐based therapy
1 finding from 1 review
Quality of life · children with cancer treated with platinum‐based therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stone‐free rate
It is very uncertain whether shock wave lithotripsy changes stone‐free rate compared with dissolution therapy (very low certainty).
1 finding from 1 review
Serious adverse events or complications of treatment
It is very uncertain whether shock wave lithotripsy changes serious adverse events or complications of treatment compared with ureteroscopy with holmium laser or pneumatic lithotripsy (very low certainty).
1 finding from 1 review
Second procedures
It is very uncertain whether shock wave lithotripsy changes second procedures compared with ureteroscopy with holmium laser or pneumatic lithotripsy (very low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
Stone‐free rate
Shock wave lithotripsy probably leads to lower stone‐free rate compared with mini‐percutaneous nephrolithotripsy (moderate certainty).
1 finding from 1 review
Serious adverse events or complications of treatment
Shock wave lithotripsy may leads to lower serious adverse events or complications of treatment compared with mini‐percutaneous nephrolithotripsy (low certainty).
1 finding from 1 review
Secondary procedures
Shock wave lithotripsy may leads to higher secondary procedures compared with mini‐percutaneous nephrolithotripsy (low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
Stone‐free rate
It is very uncertain whether percutaneous nephrolithotripsy changes stone‐free rate compared with tubeless percutaneous nephrolithotripsy (very low certainty).
1 finding from 1 review
Serious adverse events or complications of treatments
It is very uncertain whether percutaneous nephrolithotripsy changes serious adverse events or complications of treatments compared with tubeless percutaneous nephrolithotripsy (very low certainty).
1 finding from 1 review
Secondary procedures
It is very uncertain whether percutaneous nephrolithotripsy changes secondary procedures compared with tubeless percutaneous nephrolithotripsy (very low certainty).
1 finding from 1 review